Photobiomodulation Therapy for Psychiatric Disorders

This chapter explores the potential of photobiomodulation (PBM) therapy for various psychiatric disorders, providing an overview of each condition and examining the therapeutic approach in both animal studies and human clinical trials. Section 13.1 focuses on depression, discussing the problem of depression (13.1.1) and relevant animal models (13.1.2). The subsections delve into PBM therapy for depression in animal models (13.1.3.1) and human clinical studies (1.3.2), highlighting its potential as a non-invasive treatment alternative. Section 13.2 covers anxiety, discussing the problem of anxiety (2.1) and the application of PBM therapy for anxiety in human studies (13.2.2), emphasizing the potential benefits and need for further research. Section 13.3 addresses post-traumatic stress disorder (PTSD), discussing the problem of PTSD (3.1) and the application of PBM therapy for PTSD in human studies (13.3.2), highlighting promising results and areas for future investigation. Section 13.4 focuses on autism, discussing the problem of autism (13.4.1) and exploring PBM therapy for autism in animal studies (13.4.2.1) and human clinical studies (13.4.2.2), emphasizing its potential to improve core symptoms and associated comorbidities. Section 13.5 covers insomnia, discussing the problem of insomnia (13.5.1) and investigating PBM therapy for insomnia in animal studies (5.2.1) and human clinical studies (13.5.2.2), highlighting its potential to improve sleep quality and overall well-being.